(Total Views: 499)
Posted On: 06/23/2022 6:37:08 PM
Post# of 154604
Things to consider;
#1 Leronlimab's BLA Resubmission for HIV Combination.
#2 " " HIV Phase 111 Pivotal Study Monotherapy.
#3 " " Phase 11 Trial for COVID-19 Long-Hauler.
#4 " " NASH Data with Decision on BTD or Phase 111.
#5 " " mTNBC Decision for BTD or Phase 111.
#6 " " Cancer Basket Trial.
#7 " " Data from Brazil Studies with Potential EUA.
#8 Leronlimab in Critically 111 COVID-19 Study in the U.S. with Potential EUA.
#9 SEC and DOJ inquiries...What's up?
#10 Partnerships/Acquisition...What's up?
#11 Samsung and "Curing the Breach program...What's up?
#12 Vyera (Regnum) (Phoenixes AG) $4000. in Cash @ last mention...Hardly a
Marketing/Distribution Dream come through...What's up?
#13 Lucky #13...FINANCING going forward...What's up?
IS the upcoming ILC a Plenary Session.?
#1 Leronlimab's BLA Resubmission for HIV Combination.
#2 " " HIV Phase 111 Pivotal Study Monotherapy.
#3 " " Phase 11 Trial for COVID-19 Long-Hauler.
#4 " " NASH Data with Decision on BTD or Phase 111.
#5 " " mTNBC Decision for BTD or Phase 111.
#6 " " Cancer Basket Trial.
#7 " " Data from Brazil Studies with Potential EUA.
#8 Leronlimab in Critically 111 COVID-19 Study in the U.S. with Potential EUA.
#9 SEC and DOJ inquiries...What's up?
#10 Partnerships/Acquisition...What's up?
#11 Samsung and "Curing the Breach program...What's up?
#12 Vyera (Regnum) (Phoenixes AG) $4000. in Cash @ last mention...Hardly a
Marketing/Distribution Dream come through...What's up?
#13 Lucky #13...FINANCING going forward...What's up?
IS the upcoming ILC a Plenary Session.?
(3)
(0)
